Skip to content
Navigate to homepage - Cerba Research

Barc Lab, Histalim and Cerba Xpert become Cerba Research

Barc Lab, Histalim and Cerba Xpert, respective leading providers of central laboratory services, biomarker research and in-vitro diagnostics, unveil today their new umbrella brandmark and tagline which better represent the companies’ comprehensive offerings and value to their customers. 

Building on our foundations of innovation and science, our refreshed business reflects the breadth of our expanded central lab, biomarker, IVD and CDx offerings, from research and development through clinical studies and commercialization of therapies. Our intent is to change the way drug development is done by offering our combined translational biomarker offerings. Our commitment to quality, our passion and our expertise will drive Cerba Research to become the new standard in changing the shape of your clinical development and help patients to get access to new treatments faster around the world. 

Introducing a new tagline “Your Precision Medicine Partner”, the rebranding is part of the organization’s strategy to evolve and create a foundation for new opportunities. The brand identity builds upon its history of science, innovation, flexibility and quality, but also opens doors to the future. Our new website and brand showcase our capabilities and our continued commitment to our customers and their missions. From our core competencies and driven by the current challenges in the industry, we offer a whole range of services interlinking our expertise, strategy, flexibility, research, and branding. 

This rebranding marks a significant milestone in our journey, providing an opportunity to reflect on everything the original companies stood for, and everything that we aspire to become as we move forward into an exciting future. Our mission is a refined version of what we have always known best about ourselves: we deliver customized solutions by tapping into our business agility and scientific excellence. We are excited about the new year, and the new path we are headed to. Our core business and strength remain strongly rooted in providing innovative solutions, fueled by our relationship with the Cerba HealthCare Group. 

What this means for our existing clients is more capabilities offered even better professionalism you’ve come to experience. 

You’ll start to see changes to our identity, website, social media profiles, and our new visual brand signature. As we start this process, we’d like to take some time and thank our loyal clients and associates. Without you, this would not have been possible, and we look forward to a successful 2020 with all of you! 

New Year. Bigger Team. New Look. Continued Commitment… 

About Cerba Research 
Cerba Research is the merge of Barc Lab, Histalim and Cerba Xpert. All 3 entities are part of the Cerba HealthCare group and have decided to join forces under one name. 

Cerba Research provides the highest quality specialized laboratory and diagnostic solutions while leveraging patient data and scientific insight to shape and advance clinical trials. With our global footprint and access to leading regional labs, data, patients, technology, and partnered resources, we support global biotech, pharma, and IVD organizations to improve the lives of patients around the world. 

From the translation of preclinical to clinical, through commercialization, our expert scientists collaborate with you to optimize your therapeutic development and obtain critical insights earlier. We help accelerate your therapies through the development of highly specialized custom assays, deep biomarker expertise, and a passion for scientific innovation across complex therapeutic areas. Our global network of leading, specialty laboratories ensures you have access to quality data and can reach your patients. Together, we’ll improve patients’ lives around the globe. 

More information:
LinkedIn®: cerba-research
Twitter®: @cerbaresearch
Facebook®: @cerbaresearch